{"id":"288504936101-19","name":"CRISPR Therapeutics","registrationDate":"2019-10-03T21:16:47.765+02:00","category":2,"subCategory":3,"legal":"AG","web":"http://www.crisprtx.com/","country":"Switzerland","headAddress":"Baarerstrasse 14","headCity":"Zug","headPostCode":"CH","headPhone":"(41)04 15 61 32 77","boss":"Rodger Novak","bossTitle":"Mr","bossPosition":"Chairman of the Board, Founder and President","membersCount":1,"membersFTE":"0.25","membership":"","memberOrga":"","goal":"At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases","acronym":"","interests":"Public Health, Research and innovation","euInitiatives":"Crispr Therapeutics monitors policy discussions relevant to the biopharmaceutical sector in general and for the research and development of gene-based medicines in particular. We are interested in interacting with European institutions and stakeholders on all topical issues relating to healthcare policy, access to the market, research and innovation, and competitiveness.","lastUp":"2019-10-03T21:18:01.691+02:00","customers":"","costAbsolu":"","costRange":"0-9999","turnoverAbsolu":0,"turnoverRange":""}